Citations (141)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jian-Ang Li, Yefei Rong, Weilin Mao, Lei Zhang, Tiantao Kuang & Wenhui Lou. (2022) Gene expression profiling reveals the genomic changes caused by MLN4924 and the sensitizing effects of NAPEPLD knockdown in pancreatic cancer. Cell Cycle 21:2, pages 152-171.
Read now
Read now
Guang Lu, Juan Yi, Andrea Gubas, Ya-Ting Wang, Yihua Wu, Yi Ren, Man Wu, Yin Shi, Chenxi Ouyang, Hayden Weng Siong Tan, Tianru Wang, Liming Wang, Nai-Di Yang, Shuo Deng, Dajing Xia, Ruey-Hwa Chen, Sharon A. Tooze & Han-Ming Shen. (2019) Suppression of autophagy during mitosis via CUL4-RING ubiquitin ligases-mediated WIPI2 polyubiquitination and proteasomal degradation. Autophagy 15:11, pages 1917-1934.
Read now
Read now
Xin Li, Ekinci Elmira, Sagar Rohondia, Jicang Wang, Jinbao Liu & Q. Ping Dou. (2018) A patent review of the ubiquitin ligase system: 2015–2018. Expert Opinion on Therapeutic Patents 28:12, pages 919-937.
Read now
Read now
Annabelle Suisse, Miklós Békés, Tony T. Huang & Jessica E. Treisman. (2018) The COP9 signalosome inhibits Cullin-RING E3 ubiquitin ligases independently of its deneddylase activity. Fly 12:2, pages 118-126.
Read now
Read now
Maryam Oladghaffari, Jalil Pirayesh Islamian, Behzad Baradaran & Ali Shabestani Monfared. (2016) MLN4924 therapy as a novel approach in cancer treatment modalities. Journal of Chemotherapy 28:2, pages 74-82.
Read now
Read now
Román González-Prieto, Sabine AG Cuijpers, Ramesh Kumar, Ivo A Hendriks & Alfred CO Vertegaal. (2015) c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4. Cell Cycle 14:12, pages 1859-1872.
Read now
Read now
Yanchun Wang, Zhongguang Luo, Yongfu Pan, Weige Wang, Xiaoyan Zhou, Lak Shin Jeong, Yiwei Chu, Jie Liu & Lijun Jia. (2015) Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells. Cancer Biology & Therapy 16:3, pages 420-429.
Read now
Read now
Articles from other publishers (134)
Yiran Tao, Lirui Dai, Wulong Liang, Xiang Li, Yuan Lyu, Junqi Li, Zian Li, Zimin Shi, Xianyin Liang, Shaolong Zhou, Xudong Fu, Weihua Hu & Xinjun Wang. (2024) Advancements and perspectives of RBX2 as a molecular hallmark in cancer. Gene 892, pages 147864.
Crossref
Crossref
Xing Yang, Luping Chang, Zhongwang Liu, Xue Geng, Ranran Wang, Xuhui Yin, Wenying Fan & Bing-Qiao Zhao. (2024) Neddylation in the chronically hypoperfused corpus callosum: MLN4924 reduces blood-brain barrier injury via ERK5/KLF2 signaling. Experimental Neurology 371, pages 114587.
Crossref
Crossref
Sascha Röth, Nur Mehpare Kocaturk, Preethi S. Sathyamurthi, Bill Carton, Matthew Watt, Thomas J. Macartney, Kwok-Ho Chan, Albert Isidro-Llobet, Agnieszka Konopacka, Markus A. Queisser & Gopal P. Sapkota. (2023) Identification of KLHDC2 as an efficient proximity-induced degrader of K-RAS, STK33, β-catenin, and FoxP3. Cell Chemical Biology 30:10, pages 1261-1276.e7.
Crossref
Crossref
Boaz Wong, Anabel Bergeron, Glib Maznyi, Kristy Ng, Anna Jirovec, Harsimrat K. Birdi, Daniel Serrano, Marcus Spinelli, Max Thomson, Zaid Taha, Akram Alwithenani, Andrew Chen, Ian Lorimer, Barbara Vanderhyden, Rozanne Arulanandam & Jean-Simon Diallo. (2023) Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy. Molecular Therapy.
Crossref
Crossref
Akhona Vava, Juliano D. Paccez, Yihong Wang, Xuesong Gu, Manoj K. Bhasin, Michael Myers, Nelson C. Soares, Towia A. Libermann & Luiz F. Zerbini. (2023) DCUN1D1 Is an Essential Regulator of Prostate Cancer Proliferation and Tumour Growth That Acts through Neddylation of Cullin 1, 3, 4A and 5 and Deregulation of Wnt/Catenin Pathway. Cells 12:15, pages 1973.
Crossref
Crossref
Sara Petillo, Elena Sproviero, Luisa Loconte, Lorenzo Cuollo, Alessandra Zingoni, Rosa Molfetta, Cinzia Fionda, Alessandra Soriani, Cristina Cerboni, Maria Teresa Petrucci, Francesca Fazio, Rossella Paolini, Angela Santoni & Marco Cippitelli. (2023) NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells. Cell Death & Disease 14:7.
Crossref
Crossref
Rosa Molfetta, Sara Petillo, Marco Cippitelli & Rossella Paolini. (2023) SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Ruirong Wu, Xiufeng Wu, Lu Zou, Liang Zhou & Yong Mao. (2023) DDB1 regulates the activation-induced apoptosis of T cells via downregulating the expression of histone methyltransferase SETD7. Medical Oncology 40:5.
Crossref
Crossref
Farideh Kamarehei, Massoud Saidijam & Amir Taherkhani. (2023) Prognostic biomarkers and molecular pathways mediating Helicobacter pylori–induced gastric cancer: a network-biology approach. Genomics & Informatics 21:1, pages e8.
Crossref
Crossref
Tsu-Zong Yuan, Hui-Yu Lin, Chia-Hao Kuei, Che-Hsuan Lin, Hsun-Hua Lee, Hsin-Lun Lee, Hsiao-Wei Lu, Chia-Yi Su, Hui-Wen Chiu & Yuan-Feng Lin. (2023) NEDD8 promotes radioresistance via triggering autophagy formation and serves as a novel prognostic marker in oral squamous cell carcinoma. Cancer Cell International 23:1.
Crossref
Crossref
Haibo Xie, Chunrong Li, Hua Tang, Ira Tandon, Junzhuo Liao, Brett L. Roberts, Yu Zhao & Weiping Tang. (2023) Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation. Journal of Medicinal Chemistry 66:4, pages 2904-2917.
Crossref
Crossref
Jinbo Huang, Jun Zhang, Wenchao Xu, Qiong Wu, Rongsheng Zeng, Zhichao Liu, Wenhui Tao, Qian Chen, Yongqing Wang & Wei-Guo Zhu. (2022) Structure-Based Discovery of Selective Histone Deacetylase 8 Degraders with Potent Anticancer Activity. Journal of Medicinal Chemistry 66:2, pages 1186-1209.
Crossref
Crossref
Hengsen Zhang, Bin Chen, A. S. M. Waliullah, Shuhei Aramaki, Yashuang Ping, Yusuke Takanashi, Chi Zhang, Qing Zhai, Jing Yan, Soho Oyama, Tomoaki Kahyo & Mitsutoshi Setou. (2023) A New Potential Therapeutic Target for Cancer in Ubiquitin-Like Proteins—UBL3. International Journal of Molecular Sciences 24:2, pages 1231.
Crossref
Crossref
Hongmei MaoXin LinYi Sun. (2023) Neddylation Regulation of Immune Responses. Research 6.
Crossref
Crossref
Soumik Pal, Amit Sharma, Sam Padalumavunkal Mathew & Bithiah Grace Jaganathan. (2022) Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics. Frontiers in Immunology 13.
Crossref
Crossref
Hyun Mi Kang, Dae Hun Kim, Mijin Kim, Yoohong Min, Bohyeon Jeong, Kyung Hee Noh, Da Yong Lee, Hyun-Soo Cho, Nam-Soon Kim, Cho-Rok Jung & Jung Hwa Lim. (2022) FBXL17/spastin axis as a novel therapeutic target of hereditary spastic paraplegia. Cell & Bioscience 12:1.
Crossref
Crossref
Hiroshi Handa, June-Won Cheong, Yasushi Onishi, Hiroatsu Iida, Yukio Kobayashi, Hyeoung-Joon Kim, Tzeon-Jye Chiou, Koji Izutsu, Olga Tsukurov, Xiaofei Zhou, Helene Faessel, Ying Yuan, Farhad Sedarati, Douglas V. Faller, Akiko Kimura & Shang-Ju Wu. (2022) Pevonedistat in East Asian patients with acute myeloid leukemia or myelodysplastic syndromes: a phase 1/1b study to evaluate safety, pharmacokinetics and activity as a single agent and in combination with azacitidine. Journal of Hematology & Oncology 15:1.
Crossref
Crossref
Mengxiao Ge, Linlin Huang, Yinjun Ma, Shuangyi Sun, Lijun Wu, Wei Xu & Dongqin Yang. (2022) MLN4924 Treatment Diminishes Excessive Lipid Storage in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease (NAFLD) by Stimulating Hepatic Mitochondrial Fatty Acid Oxidation and Lipid Metabolites. Pharmaceutics 14:11, pages 2460.
Crossref
Crossref
Becky H. Lee, Giulia Tebaldi, Suzanne M. Pritchard & Anthony V. Nicola. (2022) Host Cell Neddylation Facilitates Alphaherpesvirus Entry in a Virus-Specific and Cell-Dependent Manner. Microbiology Spectrum 10:5.
Crossref
Crossref
Yaru Zhang, Marco Jost, Ryan A. Pak, Daniel Lu, Jing Li, Brett Lomenick, Spiros D. Garbis, Chi-Ming Li, Jonathan S. Weissman, James Russell Lipford & Raymond J. Deshaies. (2022) Adaptive exchange sustains cullin–RING ubiquitin ligase networks and proper licensing of DNA replication. Proceedings of the National Academy of Sciences 119:36.
Crossref
Crossref
Huai-liang Wu, Yue Gong, Peng Ji, Yi-fan Xie, Yi-Zhou Jiang & Guang-yu Liu. (2022) Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy. Journal of Hematology & Oncology 15:1.
Crossref
Crossref
Trace M. Jones, Claudia M. Espitia, Aikseng Ooi, Julie E. Bauman, Jennifer S. Carew & Steffan T. Nawrocki. (2022) Targeted CUL4A inhibition synergizes with cisplatin to yield long-term survival in models of head and neck squamous cell carcinoma through a DDB2-mediated mechanism. Cell Death & Disease 13:4.
Crossref
Crossref
Yiran Zhu, Bingluo Zhou, Xinyang Hu, Shilong Ying, Qiyin Zhou, Wenxia Xu, Lifeng Feng, Tianlun Hou, Xian Wang, Liyuan Zhu & Hongchuan Jin. (2022)
LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance
c‐Myc
mRNA stability
. Clinical and Translational Medicine 12:1.
Crossref
Crossref
Qiyin Zhou, Yawen Zheng & Yi Sun. (2021) Neddylation regulation of mitochondrial structure and functions. Cell & Bioscience 11:1.
Crossref
Crossref
Huilin Zhang, Ping He, Qing Zhou, Yan Lu & Bingjian Lu. (2021) The potential oncogenic and MLN4924-resistant effects of CSN5 on cervical cancer cells. Cancer Cell International 21:1.
Crossref
Crossref
Esra Albayrak, Merve Uslu, Sezer Akgol, Emre Can Tuysuz & Fatih Kocabas. (2021) Small molecule‐mediated modulation of ubiquitination and neddylation improves HSC function ex vivo. Journal of Cellular Physiology 236:12, pages 8122-8136.
Crossref
Crossref
Jinquan Liu, Bo Yuan, Jin Cao, Hongjie Luo, Shuchen Gu, Mengdi Zhang, Ran Ding, Long Zhang, Fangfang Zhou, Mien-Chie Hung, Pinglong Xu, Xia Lin, Jianping Jin & Xin-Hua Feng. (2021) AMBRA1 Promotes TGFβ Signaling via Nonproteolytic Polyubiquitylation of Smad4. Cancer Research 81:19, pages 5007-5020.
Crossref
Crossref
Sara Petillo, Cristina Capuano, Rosa Molfetta, Cinzia Fionda, Abdelilah Mekhloufi, Chiara Pighi, Fabrizio Antonangeli, Alessandra Zingoni, Alessandra Soriani, Maria Teresa Petrucci, Ricciarda Galandrini, Rossella Paolini, Angela Santoni & Marco Cippitelli. (2021) Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition. Cell Death & Disease 12:9.
Crossref
Crossref
Camilla Calandrini, Sander R. van Hooff, Irene Paassen, Dilara Ayyildiz, Sepide Derakhshan, M. Emmy M. Dolman, Karin P.S. Langenberg, Marieke van de Ven, Cecilia de Heus, Nalan Liv, Marcel Kool, Ronald R. de Krijger, Godelieve A.M. Tytgat, Marry M. van den Heuvel-Eibrink, Jan J. Molenaar & Jarno Drost. (2021) Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors. Cell Reports 36:8, pages 109568.
Crossref
Crossref
Meng-ge Du, Zhi-qiang Peng, Wen-bin Gai, Fan Liu, Wei Liu, Yu-jiao Chen, Hong-chang Li, Xin Zhang, Cui Hua Liu, Ling-qiang Zhang, Hong Jiang & Ping Xie. (2021) The Absence of PTEN in Breast Cancer Is a Driver of MLN4924 Resistance. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Dan Cojocari, Brianna N. Smith, Julie J. Purkal, Maria P. Arrate, Jason D. Huska, Yu Xiao, Agnieszka Gorska, Leah J. Hogdal, Haley E. Ramsey, Erwin R. Boghaert, Darren C. Phillips & Michael R. Savona. (2021) Pevonedistat and azacitidine upregulate NOXA (PMAIP1) to increase sensitivity to venetoclax in preclinical models of acute myeloid leukemia. Haematologica 107:4, pages 825-835.
Crossref
Crossref
Xiaofei Zhou, Farhad Sedarati, Douglas V. Faller, Dan Zhao, Hélène M. Faessel, Swapan Chowdhury, Jayaprakasam Bolleddula, Yuexian Li, Karthik Venkatakrishnan & Zsuzsanna Papai. (2020) Phase I study assessing the mass balance, pharmacokinetics, and excretion of [14C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors. Investigational New Drugs 39:2, pages 488-498.
Crossref
Crossref
Vera Vozandychova, Pavla Stojkova, Kamil Hercik, Pavel Rehulka & Jiri Stulik. (2021) The Ubiquitination System within Bacterial Host–Pathogen Interactions. Microorganisms 9:3, pages 638.
Crossref
Crossref
Xiuzhen Zhang, Tong Meng, Shuaishuai Cui, Ling Feng, Dongwu Liu, Qiuxiang Pang & Ping Wang. (2021) Ubiquitination of Nonhistone Proteins in Cancer Development and Treatment. Frontiers in Oncology 10.
Crossref
Crossref
Chen-Ming Lin, Zhengyang Jiang, Zhe Gao, Maritess Arancillo & Kevin Burgess. (2021) Small molecules targeting the NEDD8·NAE protein–protein interaction. Chemical Science 12:4, pages 1535-1543.
Crossref
Crossref
Yupei Liang, Yanyu Jiang, Xing Jin, Ping Chen, Yongqing Heng, Lili Cai, Wenjuan Zhang, Lihui Li & Lijun Jia. (2020) Neddylation inhibition activates the protective autophagy through NF-κB-catalase-ATF3 Axis in human esophageal cancer cells. Cell Communication and Signaling 18:1.
Crossref
Crossref
Mayura Meerang, Jessica Kreienbühl, Vanessa Orlowski, Seraina L. C. Müller, Michaela B. Kirschner & Isabelle Opitz. (2020) Importance of Cullin4 Ubiquitin Ligase in Malignant Pleural Mesothelioma. Cancers 12:11, pages 3460.
Crossref
Crossref
Alessandra Folci, Filippo Mirabella & Matteo Fossati. (2020) Ubiquitin and Ubiquitin-Like Proteins in the Critical Equilibrium between Synapse Physiology and Intellectual Disability. eneuro 7:4, pages ENEURO.0137-20.2020.
Crossref
Crossref
Yujiao Chen, Mengge Du, Shadamu Yusuying, Wei Liu, Yawen Tan & Ping Xie. (2020) Nedd8-activating enzyme inhibitor MLN4924 (Pevonedistat), inhibits miR-1303 to suppress human breast cancer cell proliferation via targeting p27Kip1. Experimental Cell Research 392:2, pages 112038.
Crossref
Crossref
Ainsley Mike Antao, Apoorvi Tyagi, Kye-Seong Kim & Suresh Ramakrishna. (2020) Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics. Cancers 12:6, pages 1579.
Crossref
Crossref
Gaoying Wang, Jintao Yuan, Xiu Cai, Zhiwei Xu, Jingyan Wang, Dickson K.W. Ocansey, Yongmin Yan, Hui Qian, Xu Zhang, Wenrong Xu & Fei Mao. (2020) HucMSC‐exosomes carrying miR‐326 inhibit neddylation to relieve inflammatory bowel disease in mice. Clinical and Translational Medicine 10:2.
Crossref
Crossref
Qing Yu, Yihan Jiang & Yi Sun. (2020) Anticancer drug discovery by targeting cullin neddylation. Acta Pharmaceutica Sinica B 10:5, pages 746-765.
Crossref
Crossref
Xiaonan Zhang, Stig Linder & Martina Bazzaro. (2020) Drug Development Targeting the Ubiquitin–Proteasome System (UPS) for the Treatment of Human Cancers. Cancers 12:4, pages 902.
Crossref
Crossref
Liu-Ya Wei, Zhuo-Xun Wu, Yang Yang, Min Zhao, Xiang-Yu Ma, Jin-Sui Li, Dong-Hua Yang, Zhe-Sheng Chen & Ying-Fang Fan. (2020) Overexpression of ABCG2 confers resistance to pevonedistat, an NAE inhibitor. Experimental Cell Research 388:2, pages 111858.
Crossref
Crossref
Lu Deng, Tong Meng, Lei Chen, Wenyi Wei & Ping Wang. (2020) The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref
Rishil J. Kathawala, Claudia M. Espitia, Trace M. Jones, Shariful Islam, Pranav Gupta, Yun-Kai Zhang, Zhe-Sheng Chen, Jennifer S. Carew & Steffan T. Nawrocki. (2020) ABCG2 Overexpression Contributes to Pevonedistat Resistance. Cancers 12:2, pages 429.
Crossref
Crossref
Hongmei Mao & Yi Sun. 2020. Cullin-RING Ligases and Protein Neddylation. Cullin-RING Ligases and Protein Neddylation
363
372
.
Longyuan Gong, Danrui Cui, Xiufang Xiong & Yongchao Zhao. 2020. Cullin-RING Ligases and Protein Neddylation. Cullin-RING Ligases and Protein Neddylation
317
347
.
Lisha Zhou, Yanyu Jiang, Qin Luo, Lihui Li & Lijun Jia. (2019) Neddylation: a novel modulator of the tumor microenvironment. Molecular Cancer 18:1.
Crossref
Crossref
Suji Han, Hyemi Shin, Jeong-Woo Oh, Yun Jeong Oh, Nam-Gu Her & Do-Hyun Nam. (2019) The Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling. Cancers 11:12, pages 1849.
Crossref
Crossref
Yuan YinChuan-Ming XieHua LiMingjia TanGuoan ChenRachel SchiffXiufang Xiong & Yi Sun. (2019) The FBXW2–MSX2–SOX2 axis regulates stem cell property and drug resistance of cancer cells. Proceedings of the National Academy of Sciences 116:41, pages 20528-20538.
Crossref
Crossref
Hongmei Mao, Zaiming Tang, Hua Li, Bo Sun, Mingjia Tan, Shaohua Fan, Yuan Zhu & Yi Sun. (2019) Neddylation inhibitor MLN4924 suppresses cilia formation by modulating AKT1. Protein & Cell 10:10, pages 726-744.
Crossref
Crossref
Deepak Kumar, Manasi Das, Consuelo Sauceda, Lesley G. Ellies, Karina Kuo, Purva Parwal, Mehak Kaur, Lily Jih, Gautam K. Bandyopadhyay, Douglas Burton, Rohit Loomba, Olivia Osborn & Nicholas J.G. Webster. (2019) Degradation of splicing factor SRSF3 contributes to progressive liver disease. Journal of Clinical Investigation 129:10, pages 4477-4491.
Crossref
Crossref
Shang Su, Zimo Yang, Hongying Gao, Haiyan Yang, Songbiao Zhu, Zixuan An, Juanjuan Wang, Qing Li, Sarat Chandarlapaty, Haiteng Deng, Wei Wu & Yu Rao. (2019) Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders. Journal of Medicinal Chemistry 62:16, pages 7575-7582.
Crossref
Crossref
Francesca Anna Carrieri, Philip J Murray, Dimitrinka Ditsova, Margaret Ashley Ferris, Paul Davies & Jacqueline Kim Dale. (2019)
CDK
1 and
CDK
2 regulate
NICD
1 turnover and the periodicity of the segmentation clock
. EMBO reports 20:7.
Crossref
Crossref
Wenjuan Zhou, Liying Ma, Lina Ding, Qian Guo, Zhangxu He, Jing Yang, Hui Qiao, Lingyu Li, Jie Yang, Shimin Yu, Lili Zhao, Shaomeng Wang, Hong-Min Liu, Zhenhe Suo & Wen Zhao. (2019) Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1–UBE2M Interaction. Journal of Medicinal Chemistry 62:11, pages 5382-5403.
Crossref
Crossref
Rui Hao, Yunduan Song, Runsheng Li, Yaxian Wu, Xinyi Yang, Xiaozong Li, Feng Qian, Richard D. Ye & Lei Sun. (2019) MLN4924 protects against interleukin-17A-induced pulmonary inflammation by disrupting ACT1-mediated signaling. American Journal of Physiology-Lung Cellular and Molecular Physiology 316:6, pages L1070-L1080.
Crossref
Crossref
Jinfang Zhang, Ming Chen, Yasheng Zhu, Xiangpeng Dai, Fabin Dang, Junming Ren, Shancheng Ren, Yulia V. Shulga, Francisco Beca, Wenjian Gan, Fei Wu, Yu-Min Lin, Xiaobo Zhou, James A. DeCaprio, Andrew H. Beck, Kun Ping Lu, Jiaoti Huang, Cheryl Zhao, Yinghao Sun, Xu Gao, Pier Paolo Pandolfi & Wenyi Wei. (2019) SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression. Developmental Cell 48:3, pages 329-344.e5.
Crossref
Crossref
Meng-Huang Wu, Ching-Yu Lee, Tsung-Jen Huang, Kuo-Yuan Huang, Chih-Hsin Tang, Shing-Hwa Liu, Kuan-Lin Kuo, Feng-Che Kuan, Wei-Chou Lin & Chung-Sheng Shi. (2018) MLN4924, a Protein Neddylation Inhibitor, Suppresses the Growth of Human Chondrosarcoma through Inhibiting Cell Proliferation and Inducing Endoplasmic Reticulum Stress-Related Apoptosis. International Journal of Molecular Sciences 20:1, pages 72.
Crossref
Crossref
Chun-Ping Cui, Yuan Zhang, Chanjuan Wang, Fang Yuan, Hongchang Li, Yuying Yao, Yuhan Chen, Chunnan Li, Wenyi Wei, Cui Hua Liu, Fuchu He, Yan Liu & Lingqiang Zhang. (2018) Dynamic ubiquitylation of Sox2 regulates proteostasis and governs neural progenitor cell differentiation. Nature Communications 9:1.
Crossref
Crossref
Weihua Zhou, Jie Xu, Mingjia Tan, Haomin Li, Hua Li, Wenyi Wei & Yi Sun. (2018) UBE2M Is a Stress-Inducible Dual E2 for Neddylation and Ubiquitylation that Promotes Targeted Degradation of UBE2F. Molecular Cell 70:6, pages 1008-1024.e6.
Crossref
Crossref
Lisha Zhou, Wenjuan Zhang, Yi Sun & Lijun Jia. (2018) Protein neddylation and its alterations in human cancers for targeted therapy. Cellular Signalling 44, pages 92-102.
Crossref
Crossref
Rui Wang, Jiahai Zhang, Shanhui Liao & Xiaoming Tu. (2018) 1H, 13C and 15N resonance assignments of NEDD8 from Trypanosoma brucei. Biomolecular NMR Assignments 12:1, pages 159-161.
Crossref
Crossref
Ronan T. Swords, Steven CoutreMichael B. MarisJoshua F. Zeidner, James M. ForanJose Cruz, Harry P. ErbaJesus G. BerdejaWayne Tam, Saran Vardhanabhuti, Iwona Pawlikowska-Dobler, Hélène M. Faessel, Ajeeta B. Dash, Farhad Sedarati, Bruce J. Dezube, Douglas V. Faller & Michael R. Savona. (2018) Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML. Blood 131:13, pages 1415-1424.
Crossref
Crossref
Tang-Jun Ai, Jian-Yong Sun, Lin-Juan Du, Chaoji Shi, Chao Li, Xue-Nan Sun, Yan Liu, Lihui Li, Zhixiong Xia, Lijun Jia, Jianmiao Liu & Sheng-Zhong Duan. (2017) Inhibition of neddylation by MLN4924 improves neointimal hyperplasia and promotes apoptosis of vascular smooth muscle cells through p53 and p62. Cell Death & Differentiation 25:2, pages 319-329.
Crossref
Crossref
Stacey-Lynn Paiva, Sara R. da Silva, Elvin D. de Araujo & Patrick T. Gunning. (2017) Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site. Journal of Medicinal Chemistry 61:2, pages 405-421.
Crossref
Crossref
Yongzhu LvBing LiKunna HanYang XiaoXianjun YuYong MaZhan JiaoJianjun Gao. (2018)
The Nedd8-activating enzyme inhibitor MLN4924 suppresses colon cancer cell growth
via
triggering autophagy
. The Korean Journal of Physiology & Pharmacology 22:6, pages 617.
Crossref
Crossref
Haiwei Sun, Wei Yao, Kai Wang, Yingjuan Qian, Hongjun Chen & Yong-Sam Jung. (2018) Inhibition of neddylation pathway represses influenza virus replication and pro-inflammatory responses. Virology 514, pages 230-239.
Crossref
Crossref
Sabine Schmitz & Christine DeselSabine Schmitz & Christine Desel. 2018. Der Experimentator Zellbiologie. Der Experimentator Zellbiologie
173
193
.
Qiang Xu, Guibin Lin, Huizhe Xu, Lulu Hu, Yupeng Wang, Sha Du, Wuguo Deng, Wenxian Hu, Wei Cheng & Ke Jiang. (2017) MLN4924 neddylation inhibitor promotes cell death in paclitaxel‑resistant human lung adenocarcinoma cells. Oncology Letters.
Crossref
Crossref
Y Ishikawa, K Nakayama, M Morimoto, A Mizutani, A Nakayama, K Toyoshima, A Hayashi, S Takagi, R Dairiki, H Miyashita, S Matsumoto, K Gamo, T Nomura & K Nakamura. (2017) Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication. Oncogenesis 6:9, pages e377-e377.
Crossref
Crossref
Yi Zhang, Chengcheng Shi, Li Yin, Wei Zhou, Haitao Wang, Jingjing Seng & Wencai Li. (2017) Inhibition of Mcl-1 enhances Pevonedistat-triggered apoptosis in osteosarcoma cells. Experimental Cell Research 358:2, pages 234-241.
Crossref
Crossref
Jiyou Wang, Shiwen Wang, Wenjuan Zhang, Xiaofang Wang, Xiaojun Liu, Liang Liu, Lihui Li, Yupei Liang, Jinha Yu, Lak Shin Jeong, Lijun Jia, Hu Zhao & Yanmei Zhang. (2017) Targeting neddylation pathway with MLN4924 (Pevonedistat) induces NOXA-dependent apoptosis in renal cell carcinoma. Biochemical and Biophysical Research Communications 490:4, pages 1183-1188.
Crossref
Crossref
Shuai Tong, Yang Si, Hefen Yu, Lingqiang Zhang, Ping Xie & Wenguo Jiang. (2017) MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma. Scientific Reports 7:1.
Crossref
Crossref
Mohit Misra, Maximilian Kuhn, Mark Löbel, Heeseon An, Alexander V. Statsyuk, Christoph Sotriffer & Hermann Schindelin. (2017) Dissecting the Specificity of Adenosyl Sulfamate Inhibitors Targeting the Ubiquitin-Activating Enzyme. Structure 25:7, pages 1120-1129.e3.
Crossref
Crossref
Hua Li, Weihua Zhou, Lihui Li, Jianfu Wu, Xiaoli Liu, Lili Zhao, Lijun Jia & Yi Sun. (2017) Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine. Neoplasia 19:6, pages 509-518.
Crossref
Crossref
Hao Ma, Chunlin Zhuang, Xiguo Xu, Jiao Li, Juan Wang, Xiao Min, Wannian Zhang, Huojun Zhang & Zhenyuan Miao. (2017) Discovery of benzothiazole derivatives as novel non-sulfamide NEDD8 activating enzyme inhibitors by target-based virtual screening. European Journal of Medicinal Chemistry 133, pages 174-183.
Crossref
Crossref
Kit Man Wong, Lindsey N. Micel, Heather M. Selby, Aik Choon Tan, Todd M. Pitts, Stacey M. Bagby, Anna Spreafico, Peter J. Klauck, Stephen J. Blakemore, Peter F. Smith, Alice McDonald, Allison Berger, John J. Tentler & S. Gail Eckhardt. (2016) Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924). Investigational New Drugs 35:1, pages 11-25.
Crossref
Crossref
Annabelle Suisse, DanQing He, Kevin Legent & Jessica E. Treisman. (2017) COP9 signalosome subunits protect Capicua from MAP kinase-dependent and independent mechanisms of degradation. Development.
Crossref
Crossref
Fei Wu, Xiangpeng Dai, Wenjian Gan, Lixin Wan, Min Li, Nicholas Mitsiades, Wenyi Wei, Qiang Ding & Jinfang Zhang. (2017) Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation. Cancer Letters 385, pages 207-214.
Crossref
Crossref
Tarek Abbas & Anindya Dutta. 2017. DNA Replication. DNA Replication
421
454
.
Jadd Shelton, Xiao Lu, Joseph A. Hollenbaugh, Jong Hyun Cho, Franck Amblard & Raymond F. Schinazi. (2016) Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs. Chemical Reviews 116:23, pages 14379-14455.
Crossref
Crossref
Shyam Ramachandran, Samantha R. Osterhaus, Kalpaj R. Parekh, Ashley M. Jacobi, Mark A. Behlke & Paul B. McCrayJr.Jr.. (2016) SYVN1, NEDD8, and FBXO2 Proteins Regulate ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitin-mediated Proteasomal Degradation. Journal of Biological Chemistry 291:49, pages 25489-25504.
Crossref
Crossref
Luís Korrodi-Gregório, Vanessa Soto-Cerrato, Rui Vitorino, Margarida Fardilha & Ricardo Pérez-Tomás. (2016) From Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical Research. PLOS ONE 11:11, pages e0165973.
Crossref
Crossref
Shuju Zhang, Jiaming Zhang, Zhiyuan Deng, Huadie Liu, Wei Mao, Fang Jiang, Zanxian Xia & Jia-Da Li. (2016) Circadian clock components RORα and Bmal1 mediate the anti-proliferative effect of MLN4924 in osteosarcoma cells. Oncotarget 7:40, pages 66087-66099.
Crossref
Crossref
Haiwen Li, Heng Zhu, Yang Liu, Fuchu He, Ping Xie & Lingqiang Zhang. (2016) Itch promotes the neddylation of JunB and regulates JunB-dependent transcription. Cellular Signalling 28:9, pages 1186-1195.
Crossref
Crossref
Yi Zhang, Cheng-Cheng Shi, Hua-Peng Zhang, Gong-Quan Li & Shan-Shan Li. (2016) MLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcoma. Oncotarget 7:29, pages 45263-45274.
Crossref
Crossref
Yunfei Liao, Yong Feng, Jacson Shen, Francis J. Hornicek & Zhenfeng Duan. (2015) The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma. Cancer and Metastasis Reviews 35:2, pages 151-163.
Crossref
Crossref
Xiaochen ZhouMingjia TanMukesh K. NyatiYongchao ZhaoGongxian WangYi Sun. (2016) Blockage of neddylation modification stimulates tumor sphere formation in vitro and stem cell differentiation and wound healing in vivo. Proceedings of the National Academy of Sciences 113:21.
Crossref
Crossref
V Visconte, S T Nawrocki, C M Espitia, K R Kelly, A Possemato, S A Beausoleil, Y Han, H E Carraway, A Nazha, A S Advani, J P Maciejewski, M A Sekeres & J S Carew. (2015) Comprehensive quantitative proteomic profiling of the pharmacodynamic changes induced by MLN4924 in acute myeloid leukemia cells establishes rationale for its combination with azacitidine. Leukemia 30:5, pages 1190-1194.
Crossref
Crossref
Huiyin Lan, Zaiming Tang, Hongchuan Jin & Yi Sun. (2016) Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells. Scientific Reports 6:1.
Crossref
Crossref
Hui Song, Wanwan Huai, Zhongxia Yu, Wenwen Wang, Jing Zhao, Lining Zhang & Wei Zhao. (2016) MLN4924, a First-in-Class NEDD8-Activating Enzyme Inhibitor, Attenuates IFN-β Production. The Journal of Immunology 196:7, pages 3117-3123.
Crossref
Crossref
Weijia Cai & Haifeng Yang. (2016) The structure and regulation of Cullin 2 based E3 ubiquitin ligases and their biological functions. Cell Division 11:1.
Crossref
Crossref
Yuan-Li Wang, Dan Li, Hong-Dan Yang, Lin He, Wen-Juan Sun, Ze-Lin Duan & Qun Wang. (2016) The E3 Ubiquitin Ligase CRL4 Regulates Proliferation and Progression Through Meiosis in Chinese Mitten Crab Eriocheir sinensis1. Biology of Reproduction 94:3.
Crossref
Crossref
Qiang Zhang, David Karnak, Mingjia Tan, Theodore S. Lawrence, Meredith A. Morgan & Yi Sun. (2016) FBXW7 Facilitates Nonhomologous End-Joining via K63-Linked Polyubiquitylation of XRCC4. Molecular Cell 61:3, pages 419-433.
Crossref
Crossref
Gloria Lopez-Castejon & Mariola J. Edelmann. (2016) Deubiquitinases: Novel Therapeutic Targets in Immune Surveillance?. Mediators of Inflammation 2016, pages 1-13.
Crossref
Crossref
R.J. Dohmen, J.M. Huibregtse & M. Scheffner. 2016. Encyclopedia of Cell Biology. Encyclopedia of Cell Biology
582
595
.
Shuju Wu & Lijie Yu. (2015) Targeting cullin-RING ligases for cancer treatment: rationales, advances and therapeutic implications. Cytotechnology 68:1, pages 1-8.
Crossref
Crossref
K L B Knorr, P A Schneider, X W Meng, H Dai, B D Smith, A D Hess, J E Karp & S H Kaufmann. (2015) MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors. Cell Death & Differentiation 22:12, pages 2133-2142.
Crossref
Crossref
Lan Chen, Tianyu Liu, Yunhua Tu, Dongyun Rong & Yu Cao. (2015) Cul1 promotes melanoma cell proliferation by promoting DEPTOR degradation and enhancing cap-dependent translation. Oncology Reports.
Crossref
Crossref
John Kenneth Morrow, Hui-Kuan Lin, Shao-Cong Sun & Shuxing Zhang. (2015) Targeting ubiquitination for cancer therapies. Future Medicinal Chemistry 7:17, pages 2333-2350.
Crossref
Crossref
Jeffrey Hannah & Pengbo Zhou. (2015) Distinct and overlapping functions of the cullin E3 ligase scaffolding proteins CUL4A and CUL4B. Gene 573:1, pages 33-45.
Crossref
Crossref
Sheila Mansouri & Gelareh Zadeh. (2015) Neddylation in glioblastomas. Neuro-Oncology 17:10, pages 1305-1306.
Crossref
Crossref
Wei Hua, Chunjie Li, Zixiao Yang, Lihui Li, Yanan Jiang, Guangyang Yu, Wei Zhu, Zhengyan Liu, Shengzhong Duan, Yiwei Chu, Meng Yang, Yanmei Zhang, Ying Mao & Lijun Jia. (2015) Suppression of glioblastoma by targeting the overactivated protein neddylation pathway. Neuro-Oncology 17:10, pages 1333-1343.
Crossref
Crossref
Maryam Oladghaffari, Jalil Pirayesh Islamian, Behzad Baradaran, Ali Shabestani Monfared, Alireza Farajollahi, Dariush Shanehbandi & Mohsen Mohammadi. (2015) High Efficiency Apoptosis Induction in Breast Cancer Cell Lines by MLN4924/2DG Co-Treatment. Asian Pacific Journal of Cancer Prevention 16:13, pages 5471-5476.
Crossref
Crossref
Kuan-Lin Kuo, I-Lin Ho, Chung-Sheng Shi, June-Tai Wu, Wei-Chou Lin, Yu-Chieh Tsai, Hong-Chiang Chang, Chien-Tso Chou, Chen-Hsun Hsu, Ju-Ton Hsieh, Shih-Chen Chang, Yeong-Shiau Pu & Kuo-How Huang. (2015) MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies. Cancer Letters 363:2, pages 127-136.
Crossref
Crossref
Matthias Dobbelstein & Claus Storgaard Sørensen. (2015) Exploiting replicative stress to treat cancer. Nature Reviews Drug Discovery 14:6, pages 405-423.
Crossref
Crossref
Michal Meir, Yaron Galanty, Lior Kashani, Michael Blank, Rami Khosravi, María Jesús Fernández-Ávila, Andrés Cruz-García, Ayelet Star, Lea Shochot, Yann Thomas, Lisa J. Garrett, Daniel A. Chamovitz, David M. Bodine, Thimo Kurz, Pablo Huertas, Yael Ziv & Yosef Shiloh. (2015) The COP9 signalosome is vital for timely repair of DNA double-strand breaks. Nucleic Acids Research 43:9, pages 4517-4530.
Crossref
Crossref
Zhenyu Xiao, Jer-Gung Chang, Ivo A. Hendriks, Jón Otti Sigurðsson, Jesper V. Olsen & Alfred C.O. Vertegaal. (2015) System-wide Analysis of SUMOylation Dynamics in Response to Replication Stress Reveals Novel Small Ubiquitin-like Modified Target Proteins and Acceptor Lysines Relevant for Genome Stability. Molecular & Cellular Proteomics 14:5, pages 1419-1434.
Crossref
Crossref
Emil BulatovAlessio Ciulli. (2015) Targeting Cullin–RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation. Biochemical Journal 467:3, pages 365-386.
Crossref
Crossref
Ping Chen, Tao Hu, Yupei Liang, Yanan Jiang, Yongfu Pan, Chunjie Li, Ping Zhang, Dongping Wei, Pei Li, Lak Shin Jeong, Yiwei Chu, Hui Qi, Meng Yang, Robert M. Hoffman, Ziming Dong & Lijun Jia. (2015) Synergistic inhibition of autophagy and neddylation pathways as a novel therapeutic approach for targeting liver cancer. Oncotarget 6:11, pages 9002-9017.
Crossref
Crossref
Prithviraj Bose & Steven Grant. (2015) Rational Combinations of Targeted Agents in AML. Journal of Clinical Medicine 4:4, pages 634-664.
Crossref
Crossref
Junfeng Xu, Lihui Li, Guangyang Yu, Wantao Ying, Qiang Gao, Wenjuan Zhang, Xianyu Li, Chen Ding, Yanan Jiang, Dongping Wei, Shengzhong Duan, Qunying Lei, Peng Li, Tieliu Shi, Xiaohong Qian, Jun Qin & Lijun Jia. (2015) The Neddylation-Cullin 2-RBX1 E3 Ligase Axis Targets Tumor Suppressor RhoB for Degradation in Liver Cancer. Molecular & Cellular Proteomics 14:3, pages 499-509.
Crossref
Crossref
Miroslava Stastna & Jennifer E. Van Eyk. (2015) Posttranslational modifications of lysine and evolving role in heart pathologies—Recent developments. PROTEOMICS 15:5-6, pages 1164-1180.
Crossref
Crossref
Steffan T. Nawrocki, Kevin R. Kelly, Peter G. Smith, Mignon Keaton, Hetty Carraway, Mikkael A. Sekeres, Jaroslaw P. Maciejewski & Jennifer S. Carew. (2015) The NEDD8-Activating Enzyme Inhibitor MLN4924 Disrupts Nucleotide Metabolism and Augments the Efficacy of Cytarabine. Clinical Cancer Research 21:2, pages 439-447.
Crossref
Crossref
Ya-Chao Hou & Jing-Yu Deng. (2015) Role of E3 ubiquitin ligases in gastric cancer. World Journal of Gastroenterology 21:3, pages 786.
Crossref
Crossref
Radoslav I. Enchev, Brenda A. Schulman & Matthias Peter. (2014) Protein neddylation: beyond cullin–RING ligases. Nature Reviews Molecular Cell Biology 16:1, pages 30-44.
Crossref
Crossref
Jia Liu, Shavali Shaik, Xiangpeng Dai, Qiong Wu, Xiuxia Zhou, Zhiwei Wang & Wenyi Wei. (2015) Targeting the ubiquitin pathway for cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1855:1, pages 50-60.
Crossref
Crossref
Lydia Mata-Cantero, Sofía Lobato-Gil, Fabienne Aillet, Valérie Lang & Manuel S. Rodriguez. 2015. Stress Response Pathways in Cancer. Stress Response Pathways in Cancer
225
264
.
Yongchao ZhaoMeredith A. MorganYi Sun. (2014) Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy. Antioxidants & Redox Signaling 21:17, pages 2383-2400.
Crossref
Crossref
M Tan, H Li & Y Sun. (2013) Endothelial deletion of Sag/Rbx2/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis. Oncogene 33:44, pages 5211-5220.
Crossref
Crossref
Prithviraj Bose, Yun Dai & Steven Grant. (2014) Histone deacetylase inhibitor (HDACI) mechanisms of action: Emerging insights. Pharmacology & Therapeutics 143:3, pages 323-336.
Crossref
Crossref
Shengping Zhang, Jiani Tan, Zhonghui Lai, Ying Li, Junxia Pang, Jianhu Xiao, Zhangjian Huang, Yihua Zhang, Hui Ji & Yisheng Lai. (2014) Effective Virtual Screening Strategy toward Covalent Ligands: Identification of Novel NEDD8-Activating Enzyme Inhibitors. Journal of Chemical Information and Modeling 54:6, pages 1785-1797.
Crossref
Crossref
Tsui-Ling Chang, Yi-Han Huang & Yi-Dan Ou. (2014) The role of ginsenosides in inhibiting ubiquitin activating enzyme (E1) activity. Journal of Functional Foods 7, pages 462-470.
Crossref
Crossref
W-T Yao, J-F Wu, G-Y Yu, R Wang, K Wang, L-H Li, P Chen, Y-N Jiang, H Cheng, H W Lee, J Yu, H Qi, X-J Yu, P Wang, Y-W Chu, M Yang, Z-C Hua, H-Q Ying, R M Hoffman, L S Jeong & L-J Jia. (2014) Suppression of tumor angiogenesis by targeting the protein neddylation pathway. Cell Death & Disease 5:2, pages e1059-e1059.
Crossref
Crossref
Hua Li, Mingjia Tan, Lijun Jia, Dongping Wei, Yongchao Zhao, Guoan Chen, Jie Xu, Lili Zhao, Dafydd Thomas, David G. Beer & Yi Sun. (2014) Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis. Journal of Clinical Investigation 124:2, pages 835-846.
Crossref
Crossref
Amir A. Jazaeri, Etsuko Shibata, Jonghoon Park, Jennifer L. Bryant, Mark R. Conaway, Susan C. Modesitt, Peter G. Smith, Michael A. Milhollen, Allison J. Berger & Anindya Dutta. (2013) Overcoming Platinum Resistance in Preclinical Models of Ovarian Cancer Using the Neddylation Inhibitor MLN4924. Molecular Cancer Therapeutics 12:10, pages 1958-1967.
Crossref
Crossref
Hermann AM Mucke. (2013) Patent Highlights. Pharmaceutical Patent Analyst 2:5, pages 603-610.
Crossref
Crossref
Zhong-Hua Yan, Anne Burkhardt, Huay-Keng Loke, Jesse Chen, Qing Xu, Pam Brauer, Jingya Ma, Yafang Lin, Khris Garcia, Lawrence R. Dick & Michael E. Bembenek. (2013) Quantifiable analysis of cellular pathway inhibition of a Nedd8-activating enzyme inhibitor, MLN4924, using AlphaScreen. Analytical Biochemistry 439:2, pages 109-115.
Crossref
Crossref
Steffan T. Nawrocki, Kevin R. Kelly, Peter G. Smith, Claudia M. Espitia, Anthony Possemato, Sean A. Beausoleil, Michael Milhollen, Stephen Blakemore, Michael Thomas, Allison Berger & Jennifer S. Carew. (2013) Disrupting Protein NEDDylation with MLN4924 Is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer. Clinical Cancer Research 19:13, pages 3577-3590.
Crossref
Crossref
Robert D. Junkins, Adam J. MacNeil, Zhengli Wu, Craig McCormick & Tong-Jun Lin. (2013) Regulator of Calcineurin 1 Suppresses Inflammation during Respiratory Tract Infections. The Journal of Immunology 190:10, pages 5178-5186.
Crossref
Crossref
Weihua Zhou, Wenyi Wei & Yi Sun. (2013) Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases. Cell Research 23:5, pages 599-619.
Crossref
Crossref
Chuan-Ming Xie, Wenyi Wei & Yi Sun. (2013) Role of SKP1-CUL1-F-Box-Protein (SCF) E3 Ubiquitin Ligases in Skin Cancer. Journal of Genetics and Genomics 40:3, pages 97-106.
Crossref
Crossref
Yi Sun & Hua Li. (2012) Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase. Protein & Cell 4:2, pages 103-116.
Crossref
Crossref